carbachol has been researched along with Small Cell Lung Carcinoma in 1 studies
Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.
Small Cell Lung Carcinoma: A form of highly malignant lung cancer that is composed of small ovoid cells (SMALL CELL CARCINOMA).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ami, N | 1 |
| Koga, K | 1 |
| Fushiki, H | 1 |
| Ueno, Y | 1 |
| Ogino, Y | 1 |
| Ohta, H | 1 |
1 other study available for carbachol and Small Cell Lung Carcinoma
| Article | Year |
|---|---|
Selective M3 muscarinic receptor antagonist inhibits small-cell lung carcinoma growth in a mouse orthotopic xenograft model.
Topics: Animals; Antineoplastic Agents; Calcium Signaling; Carbachol; Cell Line, Tumor; Cell Proliferation; | 2011 |